(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

VARITHENA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

VARITHENA

ST13

US500000079153260

Classe

1, 5, 10, 42, 44

Pedido

79153260

Registro

4915907

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

64

Atualização mais recente

11/05/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 10, 42, 44

Data de depósito

13/05/2014

Data de registro

15/03/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

10/05/2026

Última transação

11/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

24

Localização do titular

IE

Examinador

PARKS, KIMBERLY L

Localização atual

Historical data usage

Descrição da marca

The mark consists of the stylized word "VARITHENA".

Titulares e representantes

Titulares

BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
Provensis Limited

Representantes

Lori A. Ruhly Quarles & Brady LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in the pharmaceutical industry; chemical substances for preserving foodstuffs; chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disordersparticularly varicose veins; chemicals for use in the production of injectable foams

Classe 5

Pharmaceutical preparations for the treatment of varicose veins and arterio-venous malformations; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical products and preparations to prevent swelling in the legs; sanitary preparations for medical purposes; dietary supplements for humans and animals; medical plasters; materials for dressingsadhesives bandagesmedical and surgical adhesive tape; medical dressings; surgical dressings; wound dressings; pharmaceutical preparations in the form of foams and for use in preparing foamsfor sclerotherapyphlebologyangiologyproctologyfor treatment of oesophageal variceshydrocelesin sterilization treatment and for treatment of varicose veinsarterio-venous malformations

Classe 10

Surgical and medical apparatus for use in the treatment of varicose veinsarterio-venous malformationoesophageal varices and hydroceles; surgical and medical apparatus for use in sclerotherapyphlebologyangiologyproctologyfor the treatment of oesophageal variceshydrocelesin sterilization treatment and for the treatment of varicose veinsarterio-venous malformations; medical syringes; cannula needles for medical use; medical tubing for sclerotherapy; medical tubing for treatment of varicose veinsvenose malformationsarterio-venous malformationsoesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veinsvenous malformationsarterio-venous malformationsoesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sterilization treatment; surgical and medical apparatus for producing foams for use in sclerotherapyphlebologyangiology and proctologysterilization treatment and for treatment of varicose veinsarterio-venous malformationsoesophageal varices and hydroceles; none of the aforementioned goods being supportive bandages or compression bandages; medical devicesdevices for assessing the physical characteristics of foams for use in sclerotherapyphlebologyangiology and proctologysterilization treatment and for treatment of varicose veinsarterio-venous malformationsoesophageal varices and hydrocelesdevices for intravenous administration of such foam and devices for monitoring the position and effect of such foam in the human body; medical diagnostic devices for use in all the above medical conditions

Classe 42

Design and development of computer hardware and software; computer programming; installationmaintenance and repair of computer software; computer consultancy services; scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebologyproctology and angiology

Classe 44

Medical services; hygienic and beauty care for human beings or animals; medical analysis for the diagnosis and treatment of persons in the fields of sclerotherapyphlebologyangiology and proctology and in particularin relation to varicose veinsarterio-venous malformationsoesophageal varices and sterilization treatment; pharmaceutical advice; medical services for diagnosis in the fields of sclerotherapyphlebologyangiology and proctology andin particularin relation to varicose veinsarterio-venous malformationsoesophageal varices and sterilization treatment; medical health assessment servicesproviding post-treatment and homecare to patients in the fields of sclerotherapyphlebologyangiology and proctology andin particularin relation to varicose veinsarterio-venous malformationsoesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapyphlebologyangiology and proctology andin particularin relation to varicose veinsarterio-venous malformationsoesophageal varices and sterilization treatment; medical after-care services in the fields of sclerotherapyphlebologyangiology and proctology andin particularin relation to varicose veinsarterio-venous malformationsoesophageal varices and sterilization treatment

Publicações

Histórico de despachos e eventos da marca no USPTO.

64 publicações encontradas

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/05/2026

71AG

REGISTERED-SEC.71 ACCEPTED

10/05/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/05/2026

ES71

TEAS SECTION 71 RECEIVED

15/01/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

15/03/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

13/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/09/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/09/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/09/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/09/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

26/07/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

28/06/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

23/09/2023

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/09/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

23/07/2023

INPC

INVALIDATION PROCESSED

23/07/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

19/06/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

22/05/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

22/05/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

22/05/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

22/05/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

22/05/2023

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

19/10/2022

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

19/10/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

18/10/2022

ES75

TEAS SECTION 71 & 15 RECEIVED

15/09/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/01/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

15/03/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

13/10/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/07/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

17/06/2016

FIMP

FINAL DISPOSITION PROCESSED

17/06/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

15/06/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

15/03/2016

GPNX

NOTIFICATION PROCESSED BY IB

31/12/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

29/12/2015

PUBO

PUBLISHED FOR OPPOSITION

29/12/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/12/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/12/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/12/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

23/11/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/11/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/11/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/11/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/11/2015

ATRV

ATTORNEY REVIEW COMPLETED

19/05/2015

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

19/05/2015

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

19/05/2015

CNRT

NON-FINAL ACTION MAILED

18/05/2015

CNRT

NON-FINAL ACTION WRITTEN

17/05/2015

ALIE

ASSIGNED TO LIE

12/05/2015

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

01/05/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/04/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/04/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/04/2015

RFNT

REFUSAL PROCESSED BY IB

14/11/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/10/2014

RFRR

REFUSAL PROCESSED BY MPU

27/10/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

25/10/2014

CNRT

NON-FINAL ACTION WRITTEN

24/10/2014

MAFR

APPLICATION FILING RECEIPT MAILED

21/10/2014

DOCK

ASSIGNED TO EXAMINER

17/10/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/10/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

16/10/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace VARITHENA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.